Boston Scientific Corpora... (BSX)
NYSE: BSX
· Real-Time Price · USD
103.26
-0.89 (-0.85%)
At close: Aug 15, 2025, 10:13 AM
Boston Scientific Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.06B | 4.66B | 4.56B | 4.21B | 4.12B | 3.86B | 3.73B | 3.53B | 3.6B | 3.39B | 3.24B | 3.17B | 3.24B | 3.03B | 3.13B | 2.93B | 3.08B | 2.75B |
Cost of Revenue | 1.64B | 1.71B | 1.89B | 1.56B | 1.53B | 1.47B | 1.41B | 1.36B | 1.32B | 1.31B | 1.29B | 1.24B | 1.26B | 1.18B | 1.19B | 1.1B | 1.14B | 1.08B |
Gross Profit | 3.42B | 2.95B | 2.67B | 2.65B | 2.58B | 2.38B | 2.31B | 2.17B | 2.28B | 2.08B | 1.96B | 1.93B | 1.99B | 1.84B | 1.94B | 1.83B | 1.94B | 1.67B |
Operating Income | 943M | 896M | 589M | 674M | 747M | 644M | 558M | 558M | 551M | 515M | 449M | 460M | 477M | 457M | 457M | 442M | 511M | 360M |
Interest Income | n/a | n/a | 22M | n/a | n/a | n/a | 22M | n/a | n/a | n/a | 4M | 1M | 1M | 4M | 1M | 1M | 1M | 1M |
Pretax Income | 941M | 805M | 585M | 668M | 420M | 608M | 505M | 609M | 426M | 445M | 396M | 245M | 345M | 156M | 120M | 483M | 149M | 325M |
Net Income | 793M | 674M | 566M | 469M | 324M | 494M | 504M | 504M | 270M | 314M | 140M | 188M | 260M | 111M | 94M | 419M | 186M | 341M |
Selling & General & Admin | 1.72B | 1.6B | 1.61B | 1.56B | 1.45B | 1.36B | 1.38B | 1.24B | 1.35B | 1.22B | 1.16B | 1.12B | 1.17B | 1.06B | 1.15B | 1.07B | 1.12B | 1.02B |
Research & Development | 526M | 443M | 460M | 407M | 383M | 366M | 363M | 356M | 359M | 337M | 330M | 339M | 335M | 319M | 320M | 310M | 298M | 276M |
Other Expenses | 239M | 14M | 10M | 5M | 9M | 10M | 12M | 11M | 12M | 10M | 13M | 11M | 11M | 7M | 11M | 14M | 12M | 12M |
Operating Expenses | 2.48B | 2.05B | 2.08B | 1.97B | 1.84B | 1.74B | 1.75B | 1.61B | 1.73B | 1.56B | 1.51B | 1.47B | 1.51B | 1.39B | 1.48B | 1.39B | 1.43B | 1.31B |
Interest Expense | 90M | 87M | 139M | 83M | 81M | 72M | 67M | 67M | 71M | 67M | 64M | 65M | 64M | 295M | 88M | 86M | 88M | 89M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.12B | 3.77B | 3.97B | 3.54B | 3.37B | 3.21B | 3.17B | 2.97B | 3.05B | 2.87B | 2.79B | 2.71B | 2.77B | 2.57B | 2.67B | 2.49B | 2.57B | 2.39B |
Income Tax Expense | 146M | 133M | 23M | 200M | 98M | 115M | 1M | 105M | 156M | 131M | 256M | 57M | 85M | 45M | 26M | 64M | -37M | -16M |
Shares Outstanding (Basic) | 1.48B | 1.48B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.46B | 1.45B | 1.44B | 1.43B | 1.43B | 1.43B | 1.43B | 1.43B | 1.42B | 1.42B | 1.42B |
Shares Outstanding (Diluted) | 1.49B | 1.49B | 1.49B | 1.49B | 1.48B | 1.48B | 1.48B | 1.48B | 1.46B | 1.45B | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B | 1.43B | 1.43B |
EPS (Basic) | 0.54 | 0.46 | 0.38 | 0.32 | 0.22 | 0.34 | 0.34 | 0.34 | 0.18 | 0.21 | 0.09 | 0.12 | 0.17 | 0.07 | 0.06 | 0.28 | 0.12 | 0.23 |
EPS (Diluted) | 0.53 | 0.45 | 0.38 | 0.32 | 0.22 | 0.33 | 0.34 | 0.34 | 0.18 | 0.21 | 0.09 | 0.12 | 0.17 | 0.07 | 0.06 | 0.28 | 0.12 | 0.23 |
EBITDA | 1.03B | 1.22B | 1.07B | 1.06B | 812M | 984M | 885M | 976M | 795M | 796M | 757M | 593M | 692M | 725M | 498M | 841M | 500M | 682M |
EBIT | 1.03B | 892M | 723M | 751M | 501M | 680M | 572M | 675M | 497M | 511M | 463M | 309M | 408M | 451M | 208M | 569M | 237M | 414M |
Depreciation & Amortization | n/a | 325M | 348M | 307M | 311M | 304M | 313M | 301M | 298M | 285M | 294M | 284M | 284M | 274M | 290M | 272M | 263M | 268M |